KALA BIO, INC. Current Liabilities
KALA BIO, INC. (KALA) had Current Liabilities of $1.54 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-19
- 2026-06-30: Liabilities, Current $1.54M.
- 2026-03-31: Liabilities, Current $1.56M.
- 2025-12-31: Liabilities, Current $2.49M.
- 2025-09-30: Liabilities, Current $32.57M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.54M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $1.56M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $2.49M 10-Q · filed 2026-08-19 | |
| 2025-09-30 | $32.57M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $16.02M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $22.98M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $16.96M 10-K · filed 2026-04-15 | |
| 2024-09-30 | $23.87M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $19.19M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $11.88M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $8.35M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $10.30M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $9.85M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $10.27M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $25.68M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $40.24M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $32.89M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $32.76M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $37.42M 10-K · filed 2023-03-03 | |
| 2021-09-30 | $27.20M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $26.08M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $19.99M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $22.23M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $19.55M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $16.94M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $17.27M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $24.77M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $18.00M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $17.70M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $14.60M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $17.01M 10-K · filed 2020-02-12 | |
| 2018-09-30 | $12.69M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $9.40M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $4.97M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $14.87M 10-K · filed 2019-03-12 | $14.46M 10-K · filed 2018-04-02 |
| 2017-09-30 | $11.18M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $7.85M 10-Q · filed 2017-08-31 | |
| 2016-12-31 | $5.55M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |